Format

Send to

Choose Destination
See comment in PubMed Commons below
Curr Protoc Pharmacol. 2011 Dec;Chapter 4:Unit 4.8.1-34. doi: 10.1002/0471141755.ph0408s55.

In vitro opioid receptor assays.

Author information

1
The Department of Pharmacology and Toxicology, The Brody School of Medicine at East Carolina University, Greenville, North Carolina, USA.

Abstract

Although opioid analgesics have been used for centuries, identification of opioid receptors and the ability of an opioid receptor antagonist to block natural pain processes prompted a search for endogenous opioid peptides. In vitro models were needed to characterize opioid activity in biological samples. The longitudinal muscle/myenteric plexus (LM/MP) of the guinea pig ileum was the classical in vitro assay system, but the development of the mouse vas deferens (MVD) assay provided another important model that could be employed. Both assays entail electrical stimulation of intramural nerves to produce muscle contractions of the target organ. The robust contractions of the LM/MP are inhibited by µ and κ opioid receptor agonists, while the more labile contractions of the MVD are inhibited by µ, κ, and δ opioid receptor agonists. These in vitro assay systems are useful for evaluating biological activity of unknown substances and studying the properties of drug tolerance and both are described in this unit.

PMID:
22147348
DOI:
10.1002/0471141755.ph0408s55
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Wiley
    Loading ...
    Support Center